MICHELLE MCGUOIRK: Open Payments
NPI 1770226110 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 18 payments from 11 companies in 2025. Trend: 2023 $92 · 2024 $663 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $212 |
| CVRx, Inc. | 1 | $151 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| AtriCure, Inc. | 1 | $37 |
| La Jolla Pharmaceutical Company | 2 | $35 |
| PFIZER INC. | 1 | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: SAPIEN 3 Ultra RESILIA, Barostim Neo System, VERQUVO, WAINUA, FARXIGA, ATRICLIP LAA EXCLUSION SYSTEM, GIAPREZA, VYNDAQEL.
Industry payments across PA — which companies pay providers there.
